Nextleaf Solutions (L0MA) AI Stock Analysis

Nextleaf Solutions

(Frankfurt:L0MA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low leverageManageable leverage and positive equity provide financial flexibility while reducing balance-sheet pressure. Lower debt can preserve capacity to fund processing capabilities, commercial opportunities, or working capital without creating the interest burden associated with heavier borrowing.

Negative Factors

Revenue contractionDeclining revenue indicates that current demand, customer activity, or realized business volume is not yet expanding consistently. Continued contraction would limit operating leverage, weaken the company’s ability to absorb fixed costs, and make it harder to convert its processing platform into durable growth.

Nextleaf Solutions (L0MA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 2.42M
Dividend Yield: ―
Average Volume (3M): 550
Price to Earnings (P/E): -1.3
Beta (1Y): -0.45
Revenue Growth: -23.15%
EPS Growth: -384.00%
Country: Germany
Employees: 26
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Nextleaf Solutions Business Overview & Revenue Model

Company Description

Nextleaf Solutions Ltd. operates as a cannabis extraction technology enterprise, pioneering and licensing advanced methods for the processing, refinement, and development of cannabinoid formulations throughout Canada. The company is actively involved...

Nextleaf Solutions Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:L0MA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LOVE	77Outperform	CAD 198.55M	17.78	9.45%	―	14.66%	-33.72%
TSE:OGI	60Neutral	CAD 186.13M	2.12	21.99%	―	38.14%	2030.00%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:LABS	49Neutral	CAD 27.77M	-5.17	-13.79%	―	-6.74%	43.54%
TSE:ATLE	42Neutral	CAD 41.96M	-0.76	-2099.75%	―	-100.00%	94.43%

* Healthcare Sector Average

Performance Comparison

DE:L0MA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:L0MA	Nextleaf Solutions	0.01	-0.02	-60.61%
TSE:ATLE	Willow Biosciences	0.09	-0.09	-50.00%
TSE:OGI	Organigram Global Inc.	1.36	-0.79	-36.74%
TSE:LABS	Medipharm Labs (Otc)	0.06	-0.01	-14.29%
TSE:LOVE	Cannara Biotech, Inc.	2.02	0.33	19.53%
TSE:HASH	Simply Solventless Concentrates Ltd	0.04	-0.16	-78.57%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Nextleaf Solutions AI Stock Analysis